Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other bioactive molecules. Its primary application lies in drug discovery due to the presence of both amino groups and stereogenic center, enabling selective interactions with biological targets. Commonly employed in asymmetric synthesis and catalysis where the (R)-enantiomer provides desired stereochemical outcomes. Also utilized in the preparation of intermediates for central nervous system agents and anti-inflammatory compounds.